Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pohl

Showing results (171-180 of 189) with videos related to

Pageof 19
Sort By:
Protein Expression and Purification|August 27, 2005
Purification and antigenicity of two recombinant forms of Boophilus microplus yolk pro-cathepsin expressed in inclusion bodiesAlexandre T Leal, Paula C Pohl, Carlos A S Ferreira, et al.
Plos One|August 11, 2015
ATP Binding Cassette Transporter Mediates Both Heme and Pesticide Detoxification in Tick Midgut CellsFlavio Alves Lara, Paula C Pohl, Ana Caroline Gandara, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 31, 2010
Lesional magnetization transfer ratio: a feasible outcome for remyelinating treatment trials in multiple sclerosisI J van den Elskamp, D L Knol, H Vrenken, et al.
International Journal of Molecular Sciences|April 17, 2025
Differential Cellular Responses to Class I and II Sphingomyelinase D: Unraveling the Mechanisms of <i>Loxosceles</i> Venom-Induced Dermonecrosis and Potential Therapeutic TargetsBruna Fernandes Pinto, Priscila Hess Lopes, Carlos Eduardo Madureira Trufen, et al.
Neurology|August 19, 2011
Interferon β-1b-neutralizing antibodies 5 years after clinically isolated syndromeH-P Hartung, M S Freedman, C H Polman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 21, 2011
Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysisM S Freedman, C Metzig, L Kappos, et al.
Cancers|December 23, 2023
Charlson-Deyo Comorbidity Index as a Novel Predictor for Recurrence in Non-Muscle-Invasive Bladder CancerLukas Scheipner, Hanna Zurl, Julia V Altziebler, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 16, 2011
Can the functional assessment of multiple sclerosis adapt to changing needs? A psychometric validation in patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosisS Acaster, P Swinburn, C Wang, et al.
IEEE Engineering in Medicine and Biology Magazine : the Quarterly Magazine of the Engineering in Medicine & Biology Society|March 30, 2000
Modification of a commercially available DNA sequencer to increase sample throughputE T Stuebe, J Q Steward, A Chinwalla, et al.
Zeitschrift Fur Gastroenterologie|July 31, 1999
Anti-TNF antibody in Crohn's disease--status of information, comments and recommendations of an international working groupH Lochs, G Adler, C Beglinger, et al.
Pageof 19

Showing results (171-180 of 189) with videos related to

Sort By:
Pageof 19
Protein Expression and Purification|August 27, 2005
Purification and antigenicity of two recombinant forms of Boophilus microplus yolk pro-cathepsin expressed in inclusion bodiesAlexandre T Leal, Paula C Pohl, Carlos A S Ferreira, et al.
Plos One|August 11, 2015
ATP Binding Cassette Transporter Mediates Both Heme and Pesticide Detoxification in Tick Midgut CellsFlavio Alves Lara, Paula C Pohl, Ana Caroline Gandara, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 31, 2010
Lesional magnetization transfer ratio: a feasible outcome for remyelinating treatment trials in multiple sclerosisI J van den Elskamp, D L Knol, H Vrenken, et al.
International Journal of Molecular Sciences|April 17, 2025
Differential Cellular Responses to Class I and II Sphingomyelinase D: Unraveling the Mechanisms of <i>Loxosceles</i> Venom-Induced Dermonecrosis and Potential Therapeutic TargetsBruna Fernandes Pinto, Priscila Hess Lopes, Carlos Eduardo Madureira Trufen, et al.
Neurology|August 19, 2011
Interferon β-1b-neutralizing antibodies 5 years after clinically isolated syndromeH-P Hartung, M S Freedman, C H Polman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 21, 2011
Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysisM S Freedman, C Metzig, L Kappos, et al.
Cancers|December 23, 2023
Charlson-Deyo Comorbidity Index as a Novel Predictor for Recurrence in Non-Muscle-Invasive Bladder CancerLukas Scheipner, Hanna Zurl, Julia V Altziebler, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 16, 2011
Can the functional assessment of multiple sclerosis adapt to changing needs? A psychometric validation in patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosisS Acaster, P Swinburn, C Wang, et al.
IEEE Engineering in Medicine and Biology Magazine : the Quarterly Magazine of the Engineering in Medicine & Biology Society|March 30, 2000
Modification of a commercially available DNA sequencer to increase sample throughputE T Stuebe, J Q Steward, A Chinwalla, et al.
Zeitschrift Fur Gastroenterologie|July 31, 1999
Anti-TNF antibody in Crohn's disease--status of information, comments and recommendations of an international working groupH Lochs, G Adler, C Beglinger, et al.
Pageof 19